Theracryf (TCF)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.54p
   
  • Change Today:
      0.013p
  • 52 Week High: 1.85
  • 52 Week Low: 0.52
  • Currency: UK Pounds
  • Shares Issued: 429.62m
  • Volume: 327,031
  • Market Cap: £2.31m
  • Beta: 0.89

Regulatory News

Holding(s) in Company 15-Nov-2024 10:58 RNS
Issue of Equity and Total Voting Rights 14-Nov-2024 15:24 RNS
Notice of Results 14-Nov-2024 11:00 RNS
Passing of Dr Sue Foden, Chair 04-Nov-2024 11:00 RNS
Grant of Options and PDMR Dealings 29-Aug-2024 07:00 RNS
Holding(s) in Company 08-Aug-2024 10:23 RNS
Result of AGM 18-Jul-2024 15:02 RNS
Holding(s) in Company 17-Jul-2024 10:26 RNS
Holding(s) in Company 16-Jul-2024 12:50 RNS
Annual Financial Report and Notice of AGM 21-Jun-2024 09:00 RNS
Holding(s) in Company 13-Jun-2024 15:14 RNS
Holding(s) in Company 04-Jun-2024 15:04 RNS
Final Results - Correction 28-May-2024 16:05 RNS
Final Results 28-May-2024 07:00 RNS
Notice of R&D presentation 22-May-2024 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Theracryf Market Data

Currency UK Pounds
Share Price 0.54p
Change Today 0.013p
% Change 2.38 %
52 Week High 1.85
52 Week Low 0.52
Volume 327,031
Shares Issued 429.62m
Market Cap £2.31m
Beta 0.89

Theracryf Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
14.82% below the market average14.82% below the market average14.82% below the market average14.82% below the market average14.82% below the market average
72.00% above the sector average72.00% above the sector average72.00% above the sector average72.00% above the sector average72.00% above the sector average
Price Trend
86.02% below the market average86.02% below the market average86.02% below the market average86.02% below the market average86.02% below the market average
79.59% below the sector average79.59% below the sector average79.59% below the sector average79.59% below the sector average79.59% below the sector average
Income Not Available
Growth
17.33% below the market average17.33% below the market average17.33% below the market average17.33% below the market average17.33% below the market average
29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average

Theracryf Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
11:22 3,369 @ 0.52p
10:04 210,000 @ 0.53p
08:33 100,000 @ 0.55p
08:31 13,662 @ 0.55p

Theracryf Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page